Table 1.

Baseline characteristics of the patients.

Number of patients	85
Age [years]	50.4 ± 9.03
Female sex	83 (98%)
Weight [kg]	69.9 ± 11.7
High [cm]	1.57 ± 7.1
Body mass index [kg/m2]	28.41 ± 5.0
Cardiovascular risk factors:
Hypertension	26 (31%)
Smoking	29 (34%)
Hyperlipidemia	14 (17%)
Diabetes	10 (12%)
Chemotherapy regimen:
FECx6	30 (35%)
ACx4-T	55 (65%)
Anthracycline dose [mg/m2]	243.53 ± 4.8
Radiotherapy	36 (42%)
Beta-blockers treatment	2 (2%)
ACEI treatment	13 (15%)

Data are shown as mean standard deviation or number (percentage). FECx6 — 5-fluorouracil, epirubicin and cyclophosphamide; ACx4-T — adriamycin (doxorubicin), cyclophosphamide and Taxol^® (paclitaxel); ACEI — angiotensin-converting enzyme inhibitors